Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $441.85 | 25 | 64.1% |
| Travel and Lodging | $217.82 | 1 | 31.6% |
| Education | $29.76 | 2 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LivaNova USA, Inc. | $346.74 | 7 | $0 (2024) |
| AbbVie Inc. | $75.88 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $51.49 | 3 | $0 (2021) |
| EMD Serono, Inc. | $46.01 | 3 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $34.00 | 2 | $0 (2022) |
| Eisai Inc. | $33.12 | 2 | $0 (2018) |
| Lilly USA, LLC | $31.92 | 2 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $29.76 | 2 | $0 (2020) |
| Allergan, Inc. | $18.01 | 1 | $0 (2020) |
| Celgene Corporation | $11.66 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $217.82 | 1 | LivaNova USA, Inc. ($217.82) |
| 2023 | $97.64 | 4 | AbbVie Inc. ($45.62) |
| 2022 | $109.98 | 6 | Sunovion Pharmaceuticals Inc. ($34.00) |
| 2021 | $84.50 | 5 | Novartis Pharmaceuticals Corporation ($38.26) |
| 2020 | $63.59 | 4 | E.R. Squibb & Sons, L.L.C. ($29.76) |
| 2019 | $23.54 | 2 | LivaNova USA, Inc. ($12.70) |
| 2018 | $35.37 | 2 | Eisai Inc. ($22.14) |
| 2017 | $56.99 | 4 | EMD Serono, Inc. ($46.01) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/03/2024 | LivaNova USA, Inc. | VNS Therapy (Device) | Travel and Lodging | In-kind items and services | $217.82 | General |
| Category: Neurology | ||||||
| 08/23/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2023 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $37.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/24/2023 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Neuroscience | ||||||
| 09/12/2022 | LivaNova USA, Inc. | VNS Therapy SenTiva Model 1000 Generator (Device) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2022 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: CNS | ||||||
| 04/14/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2022 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: CNS | ||||||
| 01/24/2022 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Neuroscience | ||||||
| 12/10/2021 | LivaNova USA, Inc. | VNS - Sentiva (Device) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/04/2021 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $11.66 | General |
| Category: Neuroscience | ||||||
| 06/24/2021 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: NEUROSCIENCE | ||||||
| 02/25/2021 | LivaNova USA, Inc. | VNS - Sentiva (Device) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2020 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2020 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Education | Cash or cash equivalent | $14.88 | General |
| Category: Neuroscience | ||||||
| 09/25/2020 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Education | Cash or cash equivalent | $14.88 | General |
| Category: Neuroscience | ||||||
| 06/18/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/25/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $10.84 | General |
| Category: AED | ||||||
| 05/03/2018 | Eisai Inc. | Banzel (Drug) | Food and Beverage | Cash or cash equivalent | $22.14 | General |
| Category: Neurology | ||||||
| 04/05/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $13.23 | General |
| 11/01/2017 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $10.98 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 189 | 410 | $79,177 | $35,151 |
| 2022 | 5 | 153 | 285 | $59,419 | $25,306 |
| 2021 | 8 | 279 | 432 | $101,898 | $45,036 |
| 2020 | 8 | 253 | 395 | $86,647 | $35,342 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 241 | $26,751 | $13,962 | 52.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 77 | $12,628 | $6,247 | 49.5% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Office | 2023 | 25 | 25 | $15,925 | $6,229 | 39.1% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 20 | 22 | $11,682 | $4,056 | 34.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 24 | 28 | $7,924 | $2,879 | 36.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $4,267 | $1,778 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 147 | $16,317 | $7,824 | 48.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 78 | $12,792 | $6,179 | 48.3% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Office | 2022 | 23 | 25 | $15,925 | $5,892 | 37.0% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2022 | 17 | 20 | $10,620 | $3,794 | 35.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $3,765 | $1,618 | 43.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 110 | $18,040 | $9,283 | 51.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 62 | 143 | $15,873 | $8,847 | 55.7% |
| 93886 | Ultrasound scanning of head and neck vessel blood flow (inside the brain) | Office | 2021 | 43 | 44 | $23,364 | $7,883 | 33.7% |
| 95812 | Measurement of brain wave (eeg) activity, 41-60 minutes | Office | 2021 | 25 | 25 | $15,925 | $6,188 | 38.9% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 43 | 44 | $12,452 | $5,171 | 41.5% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 14 | 23 | $9,200 | $4,120 | 44.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $5,020 | $2,471 | 49.2% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Office | 2021 | 14 | 23 | $2,024 | $1,073 | 53.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 72 | 161 | $17,871 | $7,302 | 40.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 47 | 92 | $15,088 | $6,430 | 42.6% |
| 95812 | Measurement of brain wave (eeg) activity, 41-60 minutes | Office | 2020 | 24 | 24 | $15,288 | $5,873 | 38.4% |
| 93886 | Ultrasound scanning of head and neck vessel blood flow (inside the brain) | Office | 2020 | 29 | 29 | $15,399 | $5,299 | 34.4% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2020 | 15 | 19 | $7,600 | $3,588 | 47.2% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2020 | 29 | 29 | $8,207 | $3,452 | 42.1% |
About Dr. Arthur Smith, MD
Dr. Arthur Smith, MD is a Neurological Surgery healthcare provider based in Piedmont, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629000856.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arthur Smith, MD has received a total of $689.43 in payments from pharmaceutical and medical device companies, with $217.82 received in 2024. These payments were reported across 28 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($441.85).
As a Medicare-enrolled provider, Smith has provided services to 874 Medicare beneficiaries, totaling 1,522 services with total Medicare billing of $140,835. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Neurological Surgery
- Location Piedmont, SC
- Active Since 07/07/2006
- Last Updated 12/12/2007
- Taxonomy Code 207T00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629000856
Products in Payments
- VNS Therapy (Device) $246.34
- UBRELVY (Drug) $63.63
- Rebif (Biological) $46.01
- ZEPOSIA (Drug) $41.42
- KESIMPTA (Drug) $38.26
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $37.57
- VNS - Sentiva (Device) $34.58
- APTIOM (Drug) $34.00
- EMGALITY (Drug) $31.92
- QULIPTA (Drug) $30.26
- VNS Therapy SenTiva Model 1000 Generator (Device) $28.25
- Banzel (Drug) $22.14
- Fycompa (Drug) $10.98
- OXTELLAR XR (Drug) $10.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.